ANALYSIS OF PHENOTYPIC FEATURES AND FGFR2 MUTATIONS IN APERT SYNDROME

被引:1
|
作者
PARK, WJ
THEDA, C
MAESTRI, NE
MEYERS, GA
FRYBURG, JS
DUFRESNE, C
COHEN, MM
JABS, EW
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH MED,DEPT SURG,BALTIMORE,MD 21205
[4] UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA
[5] GEORGETOWN UNIV,DEPT PLAST SURG,WASHINGTON,DC
[6] FAIRFAX HOSP,CTR FACIAL REHABIL,FAIRFAX,VA
[7] DALHOUSIE UNIV,DEPT ORAL & MAXILLOFACIAL SURG,HALIFAX,NS,CANADA
[8] DALHOUSIE UNIV,DEPT PEDIAT,HALIFAX,NS,CANADA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A phenotypic and genotypic survey was conducted on 36 Apert syndrome patients. In all but one patient, an FGFR2 mutation, either S252W or P253R, was found in exon IIIa (exon U or 7). The frequency was 71% and 26%, for the mutations S252W and P253R, respectively. These mutations occur in the linker region between immunoglobulin-like domains II and Iii, which are involved in activation of the receptor by ligand binding and dimerization. The fact that one patient did not have a mutation in the same exon suggests further genetic heterogeneity in Apert syndrome. The frequencies of occurrence or means for measurements of 29 different clinical features (including severity of craniofacial features, syndactyly of the hands and feet, and multisystem involvement) were determined for all patients and for the two subgroups defined by their mutations. Comparison between the subgroups for the different clinical features was performed and suggested no statistically significant differences, These results are not unexpected, because the two common mutations for Apert syndrome alter FGFR2 at adjacent amino acids that are likely to have similar biological, and therefore phenotypic, consequences.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [41] Molecular analysis of exon 7 of the fibroblast growth factor receptor 2 (FGFR2) gene in an Indonesian patient with Apert syndrome: a case report
    Gara Samara Brajadenta
    Ariestya Indah Permata Sari
    Donny Nauphar
    Tiar Masykuroh Pratamawati
    Vincent Thoreau
    Journal of Medical Case Reports, 13
  • [42] Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome
    Laura R. Cornejo-Roldan
    Erich Roessler
    M. Muenke
    Human Genetics, 1999, 104 : 425 - 431
  • [43] Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome
    Cornejo-Roldan, LR
    Roessler, E
    Muenke, M
    HUMAN GENETICS, 1999, 104 (05) : 425 - 431
  • [44] IDENTICAL MUTATIONS IN THE FGFR2 GENE CAUSE BOTH PFEIFFER AND CROUZON SYNDROME PHENOTYPES
    RUTLAND, P
    PULLEYN, LJ
    REARDON, W
    BARAITSER, M
    HAYWARD, R
    JONES, B
    MALCOLM, S
    WINTER, RM
    OLDRIDGE, M
    SLANEY, SF
    POOLE, MD
    WILKIE, AOM
    NATURE GENETICS, 1995, 9 (02) : 173 - 176
  • [45] Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
    Goyal, Lipika
    Saha, Supriya K.
    Liu, Leah Y.
    Siravegna, Giulia
    Leshchiner, Ignaty
    Ahronian, Leanne G.
    Lennerz, Jochen K.
    Vu, Phuong
    Deshpande, Vikram
    Kambadakone, Avinash
    Mussolin, Benedetta
    Reyes, Stephanie
    Henderson, Laura
    Sun, Jiaoyuan Elisabeth
    Van Seventer, Emily E.
    Gurski, Joseph M., Jr.
    Baltschukat, Sabrina
    Schacher-Engstler, Barbara
    Barys, Louise
    Stamm, Christelle
    Furet, Pascal
    Ryan, David P.
    Stone, James R.
    Iafrate, A. John
    Getz, Gad
    Porta, Diana Graus
    Tiedt, Ralph
    Bardelli, Alberto
    Juric, Dejan
    Corcoran, Ryan B.
    Bardeesy, Nabeel
    Zhu, Andrew X.
    CANCER DISCOVERY, 2017, 7 (03) : 252 - 263
  • [46] Activating Somatic FGFR2 Mutations in Breast Cancer
    Reintjes, Nadine
    Li, Yun
    Becker, Alexandra
    Rohmann, Edyta
    Schmutzler, Rita
    Wollnik, Bernd
    PLOS ONE, 2013, 8 (03):
  • [47] Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients
    Goyal, Lipika
    Saha, Supriya K.
    Liu, Leah Y.
    Siravegna, Giulia
    Leshchiner, Ignaty
    Ahronian, Leanne G.
    Lennerz, Jochen K.
    Phuong Vu
    Mussolin, Benedetta
    Reyes, Stephanie
    Furet, Pascal
    Iafrate, A. John
    Getz, Gad
    Porta, Diana G.
    Tiedt, Ralph
    Bardelli, Alberto
    Juric, Dejan
    Corcoran, Ryan B.
    Bardeesy, Nabeel
    Zhu, Andrew X.
    CANCER RESEARCH, 2017, 77
  • [48] FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome
    Lin, Ying
    Gao, Hongbin
    Ai, Siming
    Eswarakumar, Jacob V. P.
    Zhu, Yi
    Chen, Chuan
    Li, Tao
    Liu, Bingqian
    Jiang, Hongye
    Liu, Yuhua
    Li, Yonghao
    Wu, Qingxiu
    Li, Haichun
    Liang, Xiaoling
    Jin, Chenjin
    Huang, Xinhua
    Lu, Lin
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 5841 - 5846
  • [49] Molecular cloning and characterization of FGFR2 in osteoblast-like cells derived from an Apert syndrome patient.
    Tanimoto, Y
    Yokozeki, M
    Matsumoto, K
    Nakanishi, H
    Hiura, K
    Moriyama, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S198 - S198
  • [50] Apert综合征患儿FGFR2基因突变分析
    刘欣
    王艳
    吴虹林
    中国优生与遗传杂志, 2014, 22 (05) : 36 - 37+65